

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.40320143 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.08282564 |
| 3 | vocalization behavior (GO:0071625) | 4.01789482 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 3.99697213 |
| 5 | glutamate receptor signaling pathway (GO:0007215) | 3.88912789 |
| 6 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.74816088 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.68244295 |
| 8 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.58055586 |
| 9 | presynaptic membrane assembly (GO:0097105) | 3.56312050 |
| 10 | postsynaptic membrane organization (GO:0001941) | 3.48269244 |
| 11 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.45517362 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.44000095 |
| 13 | synaptic transmission, glutamatergic (GO:0035249) | 3.43184110 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.42719083 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.39747072 |
| 16 | barbed-end actin filament capping (GO:0051016) | 3.37863125 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 3.28459672 |
| 18 | neuron-neuron synaptic transmission (GO:0007270) | 3.26444372 |
| 19 | protein localization to endosome (GO:0036010) | 3.26179821 |
| 20 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.23508043 |
| 21 | protein localization to synapse (GO:0035418) | 3.22854963 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.21784655 |
| 23 | presynaptic membrane organization (GO:0097090) | 3.17461818 |
| 24 | sodium ion export (GO:0071436) | 3.13857403 |
| 25 | transmission of nerve impulse (GO:0019226) | 3.09712818 |
| 26 | angiotensin maturation (GO:0002003) | 3.07066672 |
| 27 | righting reflex (GO:0060013) | 2.91815366 |
| 28 | skin morphogenesis (GO:0043589) | 2.88430204 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 2.88180544 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.85158920 |
| 31 | neuron remodeling (GO:0016322) | 2.84274370 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 2.78775082 |
| 33 | positive regulation of synapse assembly (GO:0051965) | 2.76258931 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72534118 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.71292712 |
| 36 | startle response (GO:0001964) | 2.70860646 |
| 37 | macroautophagy (GO:0016236) | 2.70488380 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70400497 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.70110619 |
| 40 | desmosome organization (GO:0002934) | 2.70041017 |
| 41 | negative regulation of cell killing (GO:0031342) | 2.68716840 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68716840 |
| 43 | myelin maintenance (GO:0043217) | 2.65003329 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 2.62852052 |
| 45 | long-term memory (GO:0007616) | 2.62668529 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.62661508 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.60401951 |
| 48 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.60007527 |
| 49 | response to pheromone (GO:0019236) | 2.59006996 |
| 50 | regulation of postsynaptic membrane potential (GO:0060078) | 2.58340344 |
| 51 | activated T cell proliferation (GO:0050798) | 2.57970924 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 2.57558166 |
| 53 | virion attachment to host cell (GO:0019062) | 2.57132085 |
| 54 | adhesion of symbiont to host cell (GO:0044650) | 2.57132085 |
| 55 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57019267 |
| 56 | positive regulation of protein dephosphorylation (GO:0035307) | 2.55858110 |
| 57 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.55262188 |
| 58 | glycolipid catabolic process (GO:0019377) | 2.54045556 |
| 59 | response to histamine (GO:0034776) | 2.53315647 |
| 60 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.51798353 |
| 61 | regulation of synapse assembly (GO:0051963) | 2.51243841 |
| 62 | neuron recognition (GO:0008038) | 2.50786099 |
| 63 | regulation of vesicle fusion (GO:0031338) | 2.50329468 |
| 64 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.48423061 |
| 65 | adhesion of symbiont to host (GO:0044406) | 2.46639881 |
| 66 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.46423630 |
| 67 | locomotory exploration behavior (GO:0035641) | 2.46280591 |
| 68 | mating behavior (GO:0007617) | 2.44977539 |
| 69 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.42723347 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.42404023 |
| 71 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.42404023 |
| 72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.42218852 |
| 73 | sexual reproduction (GO:0019953) | 2.42216173 |
| 74 | neurotransmitter secretion (GO:0007269) | 2.41541501 |
| 75 | behavioral response to pain (GO:0048266) | 2.41132303 |
| 76 | membrane depolarization (GO:0051899) | 2.40642365 |
| 77 | glutamate secretion (GO:0014047) | 2.40125589 |
| 78 | cell volume homeostasis (GO:0006884) | 2.39994642 |
| 79 | serotonin receptor signaling pathway (GO:0007210) | 2.39325163 |
| 80 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.39302408 |
| 81 | response to interleukin-15 (GO:0070672) | 2.38891504 |
| 82 | cranial nerve structural organization (GO:0021604) | 2.38842996 |
| 83 | positive regulation of membrane potential (GO:0045838) | 2.38254469 |
| 84 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.37924945 |
| 85 | stress fiber assembly (GO:0043149) | 2.37527308 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.37115104 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 2.37115104 |
| 88 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.37027093 |
| 89 | response to epinephrine (GO:0071871) | 2.36662505 |
| 90 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.36121104 |
| 91 | synapse assembly (GO:0007416) | 2.35378440 |
| 92 | membrane depolarization during action potential (GO:0086010) | 2.35091525 |
| 93 | protein retention in ER lumen (GO:0006621) | 2.34980550 |
| 94 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.34246743 |
| 95 | interferon-gamma production (GO:0032609) | 2.34032330 |
| 96 | cell adhesion mediated by integrin (GO:0033627) | 2.33955527 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 2.33593813 |
| 98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.33382265 |
| 99 | regulation of pigment cell differentiation (GO:0050932) | 2.30782635 |
| 100 | cerebellar granule cell differentiation (GO:0021707) | 2.30117677 |
| 101 | regulation of early endosome to late endosome transport (GO:2000641) | 2.29952803 |
| 102 | calcium ion import (GO:0070509) | 2.29921750 |
| 103 | limb bud formation (GO:0060174) | 2.29702801 |
| 104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.29375379 |
| 105 | cellular response to pH (GO:0071467) | 2.29223863 |
| 106 | positive regulation of action potential (GO:0045760) | 2.29029528 |
| 107 | neurotransmitter transport (GO:0006836) | 2.28840816 |
| 108 | protein localization to cilium (GO:0061512) | 2.28556207 |
| 109 | axon ensheathment in central nervous system (GO:0032291) | 2.28539635 |
| 110 | central nervous system myelination (GO:0022010) | 2.28539635 |
| 111 | regulation of synaptic vesicle transport (GO:1902803) | 2.28120588 |
| 112 | regulation of axon regeneration (GO:0048679) | 2.27190036 |
| 113 | regulation of neuron projection regeneration (GO:0070570) | 2.27190036 |
| 114 | inner ear receptor stereocilium organization (GO:0060122) | 2.27016767 |
| 115 | hypotonic response (GO:0006971) | 2.26863391 |
| 116 | regulation of neurotransmitter secretion (GO:0046928) | 2.26859877 |
| 117 | cofactor catabolic process (GO:0051187) | 2.26826576 |
| 118 | negative regulation of neurotransmitter transport (GO:0051589) | 2.26372331 |
| 119 | long-term synaptic potentiation (GO:0060291) | 2.26368049 |
| 120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.25407590 |
| 121 | definitive hemopoiesis (GO:0060216) | 2.25151069 |
| 122 | positive regulation of pseudopodium assembly (GO:0031274) | 2.25137871 |
| 123 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.25136082 |
| 124 | regulation of platelet aggregation (GO:0090330) | 2.25074415 |
| 125 | auditory behavior (GO:0031223) | 2.24101766 |
| 126 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.23592576 |
| 127 | detection of calcium ion (GO:0005513) | 2.22516326 |
| 128 | retina layer formation (GO:0010842) | 2.22269669 |
| 129 | peptide hormone processing (GO:0016486) | 2.21692958 |
| 130 | regulation of plasminogen activation (GO:0010755) | 2.21093868 |
| 131 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.20852629 |
| 132 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.20831535 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.20226622 |
| 134 | fibrinolysis (GO:0042730) | 2.20159991 |
| 135 | cell differentiation in hindbrain (GO:0021533) | 2.19554909 |
| 136 | potassium ion homeostasis (GO:0055075) | 2.19505139 |
| 137 | mechanosensory behavior (GO:0007638) | 2.19427430 |
| 138 | reflex (GO:0060004) | 2.18668351 |
| 139 | cellular response to epinephrine stimulus (GO:0071872) | 2.18470341 |
| 140 | cyclooxygenase pathway (GO:0019371) | 2.17741914 |
| 141 | opioid receptor signaling pathway (GO:0038003) | 2.17475679 |
| 142 | regulation of cholesterol homeostasis (GO:2000188) | 2.17174425 |
| 143 | learning (GO:0007612) | 2.16934727 |
| 144 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.16916601 |
| 145 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.16746124 |
| 146 | response to thyroid hormone (GO:0097066) | 2.16349871 |
| 147 | regulation of protein dephosphorylation (GO:0035304) | 2.16135498 |
| 148 | endocytic recycling (GO:0032456) | 2.15356239 |
| 149 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.14884724 |
| 150 | peptide catabolic process (GO:0043171) | 2.14686427 |
| 151 | negative regulation of fibrinolysis (GO:0051918) | 2.13562255 |
| 152 | regulation of pseudopodium assembly (GO:0031272) | 2.11797821 |
| 153 | regulation of extracellular matrix disassembly (GO:0010715) | 2.11751464 |
| 154 | L-phenylalanine catabolic process (GO:0006559) | 2.11530743 |
| 155 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.11530743 |
| 156 | synaptic vesicle maturation (GO:0016188) | 2.10149817 |
| 157 | regulation of macrophage chemotaxis (GO:0010758) | 2.07881262 |
| 158 | actin filament depolymerization (GO:0030042) | 2.07397419 |
| 159 | type B pancreatic cell proliferation (GO:0044342) | 2.06048439 |
| 160 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.05518221 |
| 161 | regulation of vitamin metabolic process (GO:0030656) | 2.05373274 |
| 162 | complement activation, classical pathway (GO:0006958) | 2.05271474 |
| 163 | mature B cell differentiation involved in immune response (GO:0002313) | 2.04537011 |
| 164 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.03829811 |
| 165 | Golgi transport vesicle coating (GO:0048200) | 2.03264322 |
| 166 | COPI coating of Golgi vesicle (GO:0048205) | 2.03264322 |
| 167 | response to acidic pH (GO:0010447) | 2.01655422 |
| 168 | ceramide catabolic process (GO:0046514) | 2.01245216 |
| 169 | hyaluronan catabolic process (GO:0030214) | 2.00162917 |
| 170 | regulation of extracellular matrix organization (GO:1903053) | 1.97726240 |
| 171 | oligosaccharide catabolic process (GO:0009313) | 1.97657059 |
| 172 | proline transport (GO:0015824) | 1.97175700 |
| 173 | actin filament capping (GO:0051693) | 1.95882911 |
| 174 | astrocyte differentiation (GO:0048708) | 1.94771898 |
| 175 | positive regulation of cellular amine metabolic process (GO:0033240) | 1.94707333 |
| 176 | response to lead ion (GO:0010288) | 1.93228267 |
| 177 | hemidesmosome assembly (GO:0031581) | 1.93053315 |
| 178 | positive regulation of receptor recycling (GO:0001921) | 1.92780829 |
| 179 | negative regulation of response to reactive oxygen species (GO:1901032) | 1.92329191 |
| 180 | regulation of complement activation (GO:0030449) | 1.92207531 |
| 181 | receptor recycling (GO:0001881) | 1.90571729 |
| 182 | response to gravity (GO:0009629) | 1.89497601 |
| 183 | negative regulation of coagulation (GO:0050819) | 1.88928695 |
| 184 | complement activation (GO:0006956) | 1.88559290 |
| 185 | regulation of protein activation cascade (GO:2000257) | 1.88225985 |
| 186 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.88098696 |
| 187 | protein carboxylation (GO:0018214) | 1.88098696 |
| 188 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.87461475 |
| 189 | response to pH (GO:0009268) | 1.86385447 |
| 190 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.85989243 |
| 191 | cellular copper ion homeostasis (GO:0006878) | 1.85169059 |
| 192 | negative regulation of hemostasis (GO:1900047) | 1.84622757 |
| 193 | negative regulation of blood coagulation (GO:0030195) | 1.84622757 |
| 194 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.84427647 |
| 195 | membrane raft organization (GO:0031579) | 1.84217881 |
| 196 | negative regulation of complement activation (GO:0045916) | 1.84076428 |
| 197 | serine transport (GO:0032329) | 1.82410929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.66843667 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.36561411 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.90641495 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73522332 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.69465257 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.67681709 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.54066791 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.50643979 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.41119416 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40947028 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.35152731 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34365263 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33309622 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29872126 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29137115 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26133493 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25169156 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25169156 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.20783061 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19294562 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18572132 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17357079 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02611141 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00751602 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97493793 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95245021 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94971920 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91792468 |
| 29 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91574952 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91436382 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.90111608 |
| 32 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87519180 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.87401640 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.86976923 |
| 35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.85623976 |
| 36 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84676765 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82204379 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.81529006 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.80037062 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78492735 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78444544 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77730467 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77711792 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73134264 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71026655 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70587894 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70199463 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69815258 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69391931 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68446834 |
| 51 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67556066 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67411762 |
| 53 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67267459 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62718694 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62259146 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61699339 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61490147 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57791726 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54621811 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54428094 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.54035267 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52279667 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52114889 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51241234 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49426611 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48359081 |
| 67 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46506075 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43995958 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43322095 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42490441 |
| 71 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41898574 |
| 72 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41381346 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41124701 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40853916 |
| 75 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39506400 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38494803 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38116076 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37844614 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37680177 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37041810 |
| 81 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35912585 |
| 82 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34825220 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34416086 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34153053 |
| 85 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32675171 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32348152 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32206237 |
| 88 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32176750 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32164344 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32077433 |
| 91 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31730301 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31106969 |
| 93 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29679960 |
| 94 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.27953600 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27143673 |
| 96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25138307 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25040513 |
| 98 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24471081 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23592341 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23052295 |
| 101 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22572725 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22227544 |
| 103 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21922450 |
| 104 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21864452 |
| 105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21033396 |
| 106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19995735 |
| 107 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19548680 |
| 108 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19272897 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18798106 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17962930 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17819206 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17429944 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17429944 |
| 114 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16477392 |
| 115 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16130014 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15834208 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15274587 |
| 118 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14810080 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14764683 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14288863 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14083737 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13923071 |
| 123 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13923071 |
| 124 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13282674 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13223903 |
| 126 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13222964 |
| 127 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13056562 |
| 128 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.12953587 |
| 129 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12442049 |
| 130 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11854220 |
| 131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10229475 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10004283 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09857483 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09172489 |
| 135 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08218583 |
| 136 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07758737 |
| 137 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07740817 |
| 138 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06211838 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06084123 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06084123 |
| 141 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06033470 |
| 142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06019798 |
| 143 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05802017 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04927767 |
| 145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04761925 |
| 146 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04571384 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04303285 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03913274 |
| 149 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.03893410 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03838221 |
| 151 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03684386 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02075938 |
| 153 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01705897 |
| 154 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01141638 |
| 155 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00502641 |
| 156 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.00483952 |
| 157 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00375012 |
| 158 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00169554 |
| 159 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99151582 |
| 160 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98736322 |
| 161 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96395982 |
| 162 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94287660 |
| 163 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92813725 |
| 164 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92630833 |
| 165 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.91526843 |
| 166 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91241594 |
| 167 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.90182999 |
| 168 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89917674 |
| 169 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88675328 |
| 170 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87222456 |
| 171 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87031866 |
| 172 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86943879 |
| 173 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86820606 |
| 174 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86126807 |
| 175 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85050815 |
| 176 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84302328 |
| 177 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84189600 |
| 178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83553308 |
| 179 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83493463 |
| 180 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82609456 |
| 181 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82467469 |
| 182 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82149697 |
| 183 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81985982 |
| 184 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80867569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.75355974 |
| 2 | MP0001188_hyperpigmentation | 3.24776678 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.16640450 |
| 4 | MP0009840_abnormal_foam_cell | 3.08296448 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.01787264 |
| 6 | MP0002735_abnormal_chemical_nociception | 2.86554068 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.86134990 |
| 8 | MP0003329_amyloid_beta_deposits | 2.75196079 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.67743975 |
| 10 | MP0009745_abnormal_behavioral_response | 2.63211601 |
| 11 | MP0002736_abnormal_nociception_after | 2.62695267 |
| 12 | MP0009046_muscle_twitch | 2.61581558 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.60133476 |
| 14 | MP0003075_altered_response_to | 2.45101206 |
| 15 | MP0001486_abnormal_startle_reflex | 2.31220299 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.25835728 |
| 17 | MP0005360_urolithiasis | 2.25396895 |
| 18 | MP0002272_abnormal_nervous_system | 2.24978693 |
| 19 | MP0002064_seizures | 2.24579205 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.19039438 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.18620034 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.09965182 |
| 23 | MP0000604_amyloidosis | 2.09103855 |
| 24 | MP0005365_abnormal_bile_salt | 2.05600954 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.05399339 |
| 26 | MP0003950_abnormal_plasma_membrane | 2.04829401 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.04700536 |
| 28 | MP0002102_abnormal_ear_morphology | 2.04544040 |
| 29 | MP0003787_abnormal_imprinting | 2.04121763 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 2.02451703 |
| 31 | MP0002063_abnormal_learning/memory/cond | 2.00688339 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.94631750 |
| 33 | MP0005409_darkened_coat_color | 1.94327278 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.92604390 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.92097936 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.88321451 |
| 37 | MP0006082_CNS_inflammation | 1.83517116 |
| 38 | MP0005166_decreased_susceptibility_to | 1.80206832 |
| 39 | MP0005165_increased_susceptibility_to | 1.79741039 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.78085658 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.76010902 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.75409660 |
| 43 | MP0004742_abnormal_vestibular_system | 1.72501792 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.68568671 |
| 45 | MP0009379_abnormal_foot_pigmentation | 1.66481576 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.65192322 |
| 47 | MP0004270_analgesia | 1.64532369 |
| 48 | MP0008569_lethality_at_weaning | 1.62587994 |
| 49 | MP0003303_peritoneal_inflammation | 1.62270170 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 1.61979102 |
| 51 | MP0001984_abnormal_olfaction | 1.61871377 |
| 52 | MP0002184_abnormal_innervation | 1.58177369 |
| 53 | MP0004142_abnormal_muscle_tone | 1.55350612 |
| 54 | MP0003690_abnormal_glial_cell | 1.54343113 |
| 55 | MP0001970_abnormal_pain_threshold | 1.52425848 |
| 56 | MP0004134_abnormal_chest_morphology | 1.51862706 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.51811656 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.48879028 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.48590082 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.46326763 |
| 61 | MP0003436_decreased_susceptibility_to | 1.45388707 |
| 62 | MP0005671_abnormal_response_to | 1.44754447 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.44082313 |
| 64 | MP0005023_abnormal_wound_healing | 1.40920560 |
| 65 | MP0009785_altered_susceptibility_to | 1.39708837 |
| 66 | MP0005410_abnormal_fertilization | 1.39682936 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.38750623 |
| 68 | MP0001905_abnormal_dopamine_level | 1.36955747 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.35667955 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.34632670 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.34032471 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.32357455 |
| 73 | MP0005275_abnormal_skin_tensile | 1.30545091 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.29598141 |
| 75 | MP0003879_abnormal_hair_cell | 1.29489927 |
| 76 | MP0000678_abnormal_parathyroid_gland | 1.28572424 |
| 77 | MP0001963_abnormal_hearing_physiology | 1.28547538 |
| 78 | MP0005171_absent_coat_pigmentation | 1.25197924 |
| 79 | MP0000343_altered_response_to | 1.23838931 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.23792280 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.22610927 |
| 82 | MP0004924_abnormal_behavior | 1.22610927 |
| 83 | MP0005174_abnormal_tail_pigmentation | 1.21409788 |
| 84 | MP0003724_increased_susceptibility_to | 1.19788865 |
| 85 | MP0002822_catalepsy | 1.19269986 |
| 86 | MP0001542_abnormal_bone_strength | 1.19255261 |
| 87 | MP0002796_impaired_skin_barrier | 1.16881228 |
| 88 | MP0003091_abnormal_cell_migration | 1.15100403 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 1.14092470 |
| 90 | MP0003763_abnormal_thymus_physiology | 1.13839607 |
| 91 | MP0004947_skin_inflammation | 1.13339955 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 1.12824794 |
| 93 | MP0003172_abnormal_lysosome_physiology | 1.12061297 |
| 94 | MP0001666_abnormal_nutrient_absorption | 1.11626808 |
| 95 | MP0002896_abnormal_bone_mineralization | 1.09679698 |
| 96 | MP0000026_abnormal_inner_ear | 1.09287777 |
| 97 | MP0001958_emphysema | 1.07434083 |
| 98 | MP0002998_abnormal_bone_remodeling | 1.06030263 |
| 99 | MP0003045_fibrosis | 1.05862302 |
| 100 | MP0000566_synostosis | 1.05378052 |
| 101 | MP0002933_joint_inflammation | 1.05147541 |
| 102 | MP0005623_abnormal_meninges_morphology | 1.05048008 |
| 103 | MP0003136_yellow_coat_color | 1.04018246 |
| 104 | MP0002332_abnormal_exercise_endurance | 1.03561140 |
| 105 | MP0002971_abnormal_brown_adipose | 1.03403782 |
| 106 | MP0001529_abnormal_vocalization | 1.02630637 |
| 107 | MP0000003_abnormal_adipose_tissue | 1.02082372 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 1.01805230 |
| 109 | MP0003195_calcinosis | 1.01790919 |
| 110 | MP0003566_abnormal_cell_adhesion | 1.01483845 |
| 111 | MP0009250_abnormal_appendicular_skeleto | 1.01126561 |
| 112 | MP0006072_abnormal_retinal_apoptosis | 1.01097540 |
| 113 | MP0005535_abnormal_body_temperature | 1.00056556 |
| 114 | MP0004381_abnormal_hair_follicle | 0.99865168 |
| 115 | MP0004510_myositis | 0.98991603 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.98810603 |
| 117 | MP0000778_abnormal_nervous_system | 0.98754465 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.98161433 |
| 119 | MP0001664_abnormal_digestion | 0.97737082 |
| 120 | MP0002060_abnormal_skin_morphology | 0.97315513 |
| 121 | MP0000858_altered_metastatic_potential | 0.97030422 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.95472098 |
| 123 | MP0005164_abnormal_response_to | 0.95427000 |
| 124 | MP0003279_aneurysm | 0.94691536 |
| 125 | MP0003634_abnormal_glial_cell | 0.93979149 |
| 126 | MP0010329_abnormal_lipoprotein_level | 0.93952376 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.92222869 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.91010019 |
| 129 | MP0004272_abnormal_basement_membrane | 0.89118654 |
| 130 | MP0002419_abnormal_innate_immunity | 0.88571419 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.88391482 |
| 132 | MP0000920_abnormal_myelination | 0.88208750 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.87978894 |
| 134 | MP0002882_abnormal_neuron_morphology | 0.87694692 |
| 135 | MP0000631_abnormal_neuroendocrine_gland | 0.86317490 |
| 136 | MP0009764_decreased_sensitivity_to | 0.86035642 |
| 137 | MP0002066_abnormal_motor_capabilities/c | 0.85981025 |
| 138 | MP0002148_abnormal_hypersensitivity_rea | 0.85711078 |
| 139 | MP0002118_abnormal_lipid_homeostasis | 0.84961232 |
| 140 | MP0005390_skeleton_phenotype | 0.83815231 |
| 141 | MP0001835_abnormal_antigen_presentation | 0.83591804 |
| 142 | MP0005387_immune_system_phenotype | 0.83237688 |
| 143 | MP0001790_abnormal_immune_system | 0.83237688 |
| 144 | MP0005501_abnormal_skin_physiology | 0.82848453 |
| 145 | MP0005379_endocrine/exocrine_gland_phen | 0.81608467 |
| 146 | MP0005025_abnormal_response_to | 0.81206417 |
| 147 | MP0000685_abnormal_immune_system | 0.80938133 |
| 148 | MP0004885_abnormal_endolymph | 0.79930985 |
| 149 | MP0004019_abnormal_vitamin_homeostasis | 0.79798340 |
| 150 | MP0001873_stomach_inflammation | 0.79789215 |
| 151 | MP0005253_abnormal_eye_physiology | 0.79762477 |
| 152 | MP0003633_abnormal_nervous_system | 0.78520627 |
| 153 | MP0001216_abnormal_epidermal_layer | 0.78462740 |
| 154 | MP0003828_pulmonary_edema | 0.78152403 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.76869524 |
| 156 | MP0010155_abnormal_intestine_physiology | 0.76810882 |
| 157 | MP0006054_spinal_hemorrhage | 0.76422537 |
| 158 | MP0008004_abnormal_stomach_pH | 0.75768144 |
| 159 | MP0002909_abnormal_adrenal_gland | 0.75582309 |
| 160 | MP0003806_abnormal_nucleotide_metabolis | 0.75157399 |
| 161 | MP0000955_abnormal_spinal_cord | 0.75095989 |
| 162 | MP0002095_abnormal_skin_pigmentation | 0.73005294 |
| 163 | MP0009697_abnormal_copulation | 0.72908348 |
| 164 | MP0000049_abnormal_middle_ear | 0.71706473 |
| 165 | MP0008874_decreased_physiological_sensi | 0.71413867 |
| 166 | MP0003868_abnormal_feces_composition | 0.69602341 |
| 167 | MP0001485_abnormal_pinna_reflex | 0.68570153 |
| 168 | MP0000372_irregular_coat_pigmentation | 0.68157627 |
| 169 | MP0005310_abnormal_salivary_gland | 0.66783170 |
| 170 | MP0001299_abnormal_eye_distance/ | 0.66577188 |
| 171 | MP0004484_altered_response_of | 0.66066529 |
| 172 | MP0002229_neurodegeneration | 0.65964808 |
| 173 | MP0002163_abnormal_gland_morphology | 0.65753633 |
| 174 | MP0005595_abnormal_vascular_smooth | 0.64891687 |
| 175 | MP0001270_distended_abdomen | 0.61173205 |
| 176 | MP0005000_abnormal_immune_tolerance | 0.60976161 |
| 177 | MP0008260_abnormal_autophagy | 0.58677525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.63512591 |
| 2 | Febrile seizures (HP:0002373) | 4.59794315 |
| 3 | Epiphyseal dysplasia (HP:0002656) | 4.11057728 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.00611475 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.00611475 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.00611475 |
| 7 | Hyperventilation (HP:0002883) | 3.68294535 |
| 8 | Vitreoretinal degeneration (HP:0000655) | 3.64889805 |
| 9 | Abnormality of incisor morphology (HP:0011063) | 3.62226465 |
| 10 | Atonic seizures (HP:0010819) | 3.61882264 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.54918226 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.51249051 |
| 13 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.39641136 |
| 14 | Absent/shortened dynein arms (HP:0200106) | 3.39641136 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.35244259 |
| 16 | Irregular epiphyses (HP:0010582) | 3.33193927 |
| 17 | Metaphyseal dysplasia (HP:0100255) | 3.31731528 |
| 18 | Focal seizures (HP:0007359) | 3.21553600 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.16955813 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.11316737 |
| 21 | Abnormality of binocular vision (HP:0011514) | 2.92869078 |
| 22 | Diplopia (HP:0000651) | 2.92869078 |
| 23 | Mitral stenosis (HP:0001718) | 2.91856954 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 2.90766467 |
| 25 | Vertebral compression fractures (HP:0002953) | 2.85325472 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.72943195 |
| 27 | Complement deficiency (HP:0004431) | 2.72201864 |
| 28 | Myokymia (HP:0002411) | 2.71492828 |
| 29 | Vascular calcification (HP:0004934) | 2.70231200 |
| 30 | Broad-based gait (HP:0002136) | 2.69196414 |
| 31 | Axonal loss (HP:0003447) | 2.64630440 |
| 32 | Hypothermia (HP:0002045) | 2.62233936 |
| 33 | Congenital stationary night blindness (HP:0007642) | 2.60827729 |
| 34 | White forelock (HP:0002211) | 2.59431306 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.58472756 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 2.57899801 |
| 37 | Amyloidosis (HP:0011034) | 2.57529469 |
| 38 | Action tremor (HP:0002345) | 2.56749445 |
| 39 | Abnormality of complement system (HP:0005339) | 2.56079692 |
| 40 | Patchy hypopigmentation of hair (HP:0011365) | 2.55280146 |
| 41 | Tubulointerstitial nephritis (HP:0001970) | 2.53484183 |
| 42 | Deep venous thrombosis (HP:0002625) | 2.53307276 |
| 43 | Growth hormone excess (HP:0000845) | 2.50401511 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.49656900 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.49380303 |
| 46 | Short femoral neck (HP:0100864) | 2.48098092 |
| 47 | Small epiphyses (HP:0010585) | 2.47033127 |
| 48 | Absence seizures (HP:0002121) | 2.43756089 |
| 49 | Malnutrition (HP:0004395) | 2.43537903 |
| 50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42811592 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40209250 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40209250 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40209250 |
| 54 | Mixed hearing impairment (HP:0000410) | 2.39993500 |
| 55 | Protrusio acetabuli (HP:0003179) | 2.39532655 |
| 56 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.38367577 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.36732808 |
| 58 | Hydroxyprolinuria (HP:0003080) | 2.36732808 |
| 59 | Abnormality of the vertebral endplates (HP:0005106) | 2.31511512 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30988313 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.30988313 |
| 62 | Aplasia cutis congenita (HP:0001057) | 2.30825063 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.30465603 |
| 64 | Abnormality of the nasal septum (HP:0000419) | 2.28251650 |
| 65 | Generalized tonic-clonic seizures (HP:0002069) | 2.26160271 |
| 66 | Abnormal ciliary motility (HP:0012262) | 2.25448515 |
| 67 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.23814339 |
| 68 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.23814339 |
| 69 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.23600137 |
| 70 | Hypoplastic ischia (HP:0003175) | 2.20653080 |
| 71 | Diminished motivation (HP:0000745) | 2.19632821 |
| 72 | Xanthomatosis (HP:0000991) | 2.18584142 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.17738939 |
| 74 | Hyperparathyroidism (HP:0000843) | 2.17214935 |
| 75 | Abnormal hair whorl (HP:0010721) | 2.17140837 |
| 76 | Mutism (HP:0002300) | 2.16066768 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.15654903 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.15654903 |
| 79 | Dialeptic seizures (HP:0011146) | 2.15191630 |
| 80 | Abnormality of the ischium (HP:0003174) | 2.14277921 |
| 81 | Atrophic scars (HP:0001075) | 2.14088176 |
| 82 | Apathy (HP:0000741) | 2.13678058 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 2.12488074 |
| 84 | Genu varum (HP:0002970) | 2.11604472 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 2.10829704 |
| 86 | Absent frontal sinuses (HP:0002688) | 2.10773614 |
| 87 | Fibular hypoplasia (HP:0003038) | 2.10286019 |
| 88 | Chronic hepatic failure (HP:0100626) | 2.09206674 |
| 89 | Chronic sinusitis (HP:0011109) | 2.08979546 |
| 90 | Visual hallucinations (HP:0002367) | 2.07773343 |
| 91 | Intention tremor (HP:0002080) | 2.06875987 |
| 92 | Decreased central vision (HP:0007663) | 2.06225953 |
| 93 | Upper limb muscle weakness (HP:0003484) | 2.06039685 |
| 94 | Delusions (HP:0000746) | 2.05162303 |
| 95 | Progressive neurologic deterioration (HP:0002344) | 2.04822459 |
| 96 | Fat malabsorption (HP:0002630) | 2.03371974 |
| 97 | Spastic paraparesis (HP:0002313) | 2.03201144 |
| 98 | Retinal dysplasia (HP:0007973) | 2.02098602 |
| 99 | Agammaglobulinemia (HP:0004432) | 2.01557805 |
| 100 | Achilles tendon contracture (HP:0001771) | 2.01444598 |
| 101 | Esotropia (HP:0000565) | 2.00710729 |
| 102 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00254852 |
| 103 | Fair hair (HP:0002286) | 1.99981872 |
| 104 | Cupped ribs (HP:0000887) | 1.98946276 |
| 105 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98254427 |
| 106 | Steatorrhea (HP:0002570) | 1.97988254 |
| 107 | Nuclear cataract (HP:0100018) | 1.97370455 |
| 108 | Flat capital femoral epiphysis (HP:0003370) | 1.97345325 |
| 109 | Bradycardia (HP:0001662) | 1.96277482 |
| 110 | Acanthosis nigricans (HP:0000956) | 1.94653482 |
| 111 | Short tibia (HP:0005736) | 1.93585737 |
| 112 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92708716 |
| 113 | Hand muscle atrophy (HP:0009130) | 1.90733839 |
| 114 | Glomerulonephritis (HP:0000099) | 1.90036810 |
| 115 | Loss of speech (HP:0002371) | 1.90026686 |
| 116 | Arthropathy (HP:0003040) | 1.89869909 |
| 117 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.89470862 |
| 118 | Generalized hypopigmentation of hair (HP:0011358) | 1.88196757 |
| 119 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87985587 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87985587 |
| 121 | Absent speech (HP:0001344) | 1.87653130 |
| 122 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.87564035 |
| 123 | Metaphyseal irregularity (HP:0003025) | 1.86687870 |
| 124 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86334765 |
| 125 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.85908643 |
| 126 | Rigidity (HP:0002063) | 1.84909012 |
| 127 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.84671804 |
| 128 | Menstrual irregularities (HP:0000858) | 1.83254106 |
| 129 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.82270393 |
| 130 | Abnormality of femoral epiphyses (HP:0006499) | 1.82270393 |
| 131 | Fragile skin (HP:0001030) | 1.80801443 |
| 132 | Morphological abnormality of the middle ear (HP:0008609) | 1.80711663 |
| 133 | Narrow nasal bridge (HP:0000446) | 1.80230643 |
| 134 | Limb dystonia (HP:0002451) | 1.80201708 |
| 135 | Mild short stature (HP:0003502) | 1.79928408 |
| 136 | Alopecia of scalp (HP:0002293) | 1.79155861 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.79105771 |
| 138 | Paraparesis (HP:0002385) | 1.79016071 |
| 139 | Interstitial pulmonary disease (HP:0006530) | 1.78015107 |
| 140 | Dysdiadochokinesis (HP:0002075) | 1.77543252 |
| 141 | Abnormal tarsal ossification (HP:0008369) | 1.77355237 |
| 142 | Neuronal loss in central nervous system (HP:0002529) | 1.76291396 |
| 143 | Scanning speech (HP:0002168) | 1.76197672 |
| 144 | Hydroureter (HP:0000072) | 1.75858052 |
| 145 | Ankle clonus (HP:0011448) | 1.75543347 |
| 146 | Palmoplantar hyperkeratosis (HP:0000972) | 1.75164876 |
| 147 | Slow saccadic eye movements (HP:0000514) | 1.74970230 |
| 148 | Medial flaring of the eyebrow (HP:0010747) | 1.74250892 |
| 149 | Plantar hyperkeratosis (HP:0007556) | 1.74149997 |
| 150 | Erythema (HP:0010783) | 1.73552139 |
| 151 | Irregular vertebral endplates (HP:0003301) | 1.73269135 |
| 152 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.72816217 |
| 153 | Flattened epiphyses (HP:0003071) | 1.71698259 |
| 154 | Aplasia involving bones of the extremities (HP:0009825) | 1.71216650 |
| 155 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.71216650 |
| 156 | Aplasia of the phalanges of the hand (HP:0009802) | 1.71216650 |
| 157 | Right ventricular cardiomyopathy (HP:0011663) | 1.71074446 |
| 158 | Distal lower limb amyotrophy (HP:0008944) | 1.70128239 |
| 159 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.70047103 |
| 160 | Abnormality of macrophages (HP:0004311) | 1.69944631 |
| 161 | Stridor (HP:0010307) | 1.69361371 |
| 162 | Submucous cleft hard palate (HP:0000176) | 1.67183426 |
| 163 | Nasolacrimal duct obstruction (HP:0000579) | 1.66628047 |
| 164 | Enlarged epiphyses (HP:0010580) | 1.66268663 |
| 165 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.66175486 |
| 166 | Episodic fever (HP:0001954) | 1.66148214 |
| 167 | Abnormality of the incisor (HP:0000676) | 1.66022327 |
| 168 | Purpura (HP:0000979) | 1.65947739 |
| 169 | Neonatal death (HP:0003811) | 1.65504642 |
| 170 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.65332210 |
| 171 | Protruding tongue (HP:0010808) | 1.64453972 |
| 172 | Blue irides (HP:0000635) | 1.64266042 |
| 173 | Dementia (HP:0000726) | 1.63919748 |
| 174 | Dysmetria (HP:0001310) | 1.63803380 |
| 175 | Torticollis (HP:0000473) | 1.63659671 |
| 176 | Conjugated hyperbilirubinemia (HP:0002908) | 1.62749886 |
| 177 | Attenuation of retinal blood vessels (HP:0007843) | 1.62321321 |
| 178 | Focal dystonia (HP:0004373) | 1.62294083 |
| 179 | Septo-optic dysplasia (HP:0100842) | 1.62074949 |
| 180 | Osteoarthritis (HP:0002758) | 1.61015998 |
| 181 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.60883770 |
| 182 | Hypercortisolism (HP:0001578) | 1.60455366 |
| 183 | Aortic aneurysm (HP:0004942) | 1.60086429 |
| 184 | Hypertriglyceridemia (HP:0002155) | 1.60078210 |
| 185 | Cerebral aneurysm (HP:0004944) | 1.59903361 |
| 186 | Gait imbalance (HP:0002141) | 1.59855473 |
| 187 | Osteolytic defects of the hand bones (HP:0009699) | 1.58894355 |
| 188 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.58894355 |
| 189 | Abnormality of the femoral head (HP:0003368) | 1.58654720 |
| 190 | Nonprogressive disorder (HP:0003680) | 1.58539316 |
| 191 | Congenital sensorineural hearing impairment (HP:0008527) | 1.58120424 |
| 192 | Tetraparesis (HP:0002273) | 1.57775718 |
| 193 | Cranial hyperostosis (HP:0004437) | 1.57401961 |
| 194 | Increased CSF protein (HP:0002922) | 1.57039869 |
| 195 | Craniofacial dystonia (HP:0012179) | 1.56798904 |
| 196 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.55716966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.47279633 |
| 2 | TESK1 | 3.77035456 |
| 3 | TNIK | 3.21129109 |
| 4 | NTRK3 | 3.05996724 |
| 5 | MST1R | 3.00944914 |
| 6 | MAP2K7 | 2.91921455 |
| 7 | MAP3K12 | 2.85746511 |
| 8 | RIPK1 | 2.70756751 |
| 9 | TXK | 2.65711293 |
| 10 | EPHA2 | 2.50098439 |
| 11 | SIK3 | 2.46897315 |
| 12 | BLK | 2.40544555 |
| 13 | IRAK3 | 2.25849560 |
| 14 | SIK2 | 2.02975028 |
| 15 | FES | 2.01687252 |
| 16 | ARAF | 1.94501974 |
| 17 | ERN1 | 1.92144994 |
| 18 | PRPF4B | 1.91735577 |
| 19 | EPHA4 | 1.91577712 |
| 20 | MUSK | 1.90303269 |
| 21 | LIMK1 | 1.87157896 |
| 22 | MAP3K13 | 1.83815544 |
| 23 | RIPK4 | 1.70227312 |
| 24 | MAP3K11 | 1.70057731 |
| 25 | PIM2 | 1.70009291 |
| 26 | MAP3K4 | 1.69056125 |
| 27 | TBK1 | 1.51295109 |
| 28 | GRK7 | 1.48267997 |
| 29 | PRKD3 | 1.44785272 |
| 30 | ADRBK2 | 1.42607117 |
| 31 | MOS | 1.41907303 |
| 32 | EPHB2 | 1.41415151 |
| 33 | MAP3K3 | 1.40879152 |
| 34 | NEK6 | 1.40233397 |
| 35 | TNK2 | 1.40059148 |
| 36 | MAPK13 | 1.37545282 |
| 37 | STK38 | 1.37398912 |
| 38 | GRK1 | 1.37349522 |
| 39 | LMTK2 | 1.36284250 |
| 40 | MKNK2 | 1.35569890 |
| 41 | MAP3K14 | 1.34298308 |
| 42 | PAK6 | 1.33952832 |
| 43 | ABL2 | 1.33023573 |
| 44 | STK16 | 1.26767473 |
| 45 | BMPR2 | 1.25893148 |
| 46 | MET | 1.25537541 |
| 47 | EPHB1 | 1.23165706 |
| 48 | TIE1 | 1.21522909 |
| 49 | CDK19 | 1.21442249 |
| 50 | PRKD2 | 1.20876643 |
| 51 | TEC | 1.19284060 |
| 52 | PTK2 | 1.19092147 |
| 53 | PLK2 | 1.18845782 |
| 54 | PIK3CA | 1.13535744 |
| 55 | PDGFRA | 1.12851958 |
| 56 | GRK5 | 1.11729046 |
| 57 | NME2 | 1.10618344 |
| 58 | UHMK1 | 1.07748207 |
| 59 | TYK2 | 1.06479215 |
| 60 | IRAK4 | 1.05962836 |
| 61 | KSR2 | 1.05613450 |
| 62 | NLK | 1.04498334 |
| 63 | TESK2 | 1.03989027 |
| 64 | CAMKK2 | 1.03973907 |
| 65 | NME1 | 1.03383506 |
| 66 | IRAK1 | 1.00016646 |
| 67 | PDPK1 | 0.96286624 |
| 68 | NUAK1 | 0.96141424 |
| 69 | MARK1 | 0.95568856 |
| 70 | CAMK2G | 0.95460553 |
| 71 | MAP2K4 | 0.94919802 |
| 72 | TGFBR2 | 0.93293528 |
| 73 | PINK1 | 0.89828507 |
| 74 | TAOK2 | 0.89274855 |
| 75 | IKBKE | 0.89063850 |
| 76 | DYRK1A | 0.87432097 |
| 77 | CAMK2A | 0.86009521 |
| 78 | PRKCE | 0.85369555 |
| 79 | BMPR1B | 0.85217858 |
| 80 | TRPM7 | 0.83307907 |
| 81 | MINK1 | 0.83017402 |
| 82 | MAP3K1 | 0.82517503 |
| 83 | INSRR | 0.82168841 |
| 84 | SGK2 | 0.82126166 |
| 85 | NTRK2 | 0.80989666 |
| 86 | CAMK1 | 0.80285020 |
| 87 | MAPK12 | 0.79575672 |
| 88 | JAK1 | 0.79553177 |
| 89 | PKN1 | 0.79002875 |
| 90 | ITK | 0.78553692 |
| 91 | FGR | 0.76668087 |
| 92 | PRKCQ | 0.75843213 |
| 93 | MYLK | 0.75583800 |
| 94 | MAP4K1 | 0.75349677 |
| 95 | CDC42BPA | 0.74988558 |
| 96 | DAPK3 | 0.74516862 |
| 97 | PRKCG | 0.73740331 |
| 98 | NTRK1 | 0.71832931 |
| 99 | MAP3K9 | 0.70806601 |
| 100 | MAP3K2 | 0.70723487 |
| 101 | FGFR4 | 0.70709906 |
| 102 | IRAK2 | 0.70455973 |
| 103 | YES1 | 0.69543654 |
| 104 | PDK1 | 0.68285653 |
| 105 | LATS2 | 0.68195162 |
| 106 | SYK | 0.67617232 |
| 107 | EPHA3 | 0.67067556 |
| 108 | CDK8 | 0.66648863 |
| 109 | PTK2B | 0.65549647 |
| 110 | PAK4 | 0.65368428 |
| 111 | CDK5 | 0.64856251 |
| 112 | CDK3 | 0.63445754 |
| 113 | CAMK2B | 0.63101706 |
| 114 | STK24 | 0.61983786 |
| 115 | LCK | 0.61743940 |
| 116 | MAP3K5 | 0.61741268 |
| 117 | PRKG1 | 0.60739271 |
| 118 | MARK2 | 0.60462764 |
| 119 | ROCK2 | 0.59617357 |
| 120 | IKBKB | 0.56895085 |
| 121 | EIF2AK2 | 0.56583097 |
| 122 | SGK494 | 0.54569809 |
| 123 | SGK223 | 0.54569809 |
| 124 | FYN | 0.51780438 |
| 125 | HCK | 0.51399551 |
| 126 | PDK2 | 0.51399019 |
| 127 | DAPK2 | 0.51069782 |
| 128 | ZAP70 | 0.50537358 |
| 129 | PHKG1 | 0.50348399 |
| 130 | PHKG2 | 0.50348399 |
| 131 | OXSR1 | 0.50219208 |
| 132 | PRKG2 | 0.49982529 |
| 133 | HIPK2 | 0.49778509 |
| 134 | MAP2K6 | 0.49715336 |
| 135 | ADRBK1 | 0.49570335 |
| 136 | WNK1 | 0.48820386 |
| 137 | TAOK1 | 0.48768073 |
| 138 | LYN | 0.47428012 |
| 139 | FGFR3 | 0.46973554 |
| 140 | CAMK2D | 0.45899152 |
| 141 | MAP2K3 | 0.45454419 |
| 142 | JAK3 | 0.45182351 |
| 143 | KIT | 0.45022135 |
| 144 | KSR1 | 0.44453034 |
| 145 | KDR | 0.44218882 |
| 146 | DYRK1B | 0.44122502 |
| 147 | SGK1 | 0.44086355 |
| 148 | GSK3A | 0.43317246 |
| 149 | TAOK3 | 0.43289388 |
| 150 | GRK6 | 0.42752834 |
| 151 | MAPK4 | 0.41887351 |
| 152 | PRKACA | 0.41614323 |
| 153 | MAPK7 | 0.40604011 |
| 154 | DAPK1 | 0.40375678 |
| 155 | ROCK1 | 0.39877206 |
| 156 | PRKCH | 0.38623161 |
| 157 | CDK14 | 0.38506867 |
| 158 | DDR2 | 0.36631209 |
| 159 | BTK | 0.36080662 |
| 160 | BCR | 0.34935842 |
| 161 | FER | 0.34868767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.91372333 |
| 2 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.57640782 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48878075 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 2.44987008 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32053741 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.31945668 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 2.22855493 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.19577561 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15306263 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10588477 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.08533547 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.06480313 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.06286108 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.01922586 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.00255637 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.93942427 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87830095 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.85157114 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81530917 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75909093 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.67192071 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.65755020 |
| 23 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.64773733 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.58400507 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57739103 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.57206918 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53719569 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.52703040 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.49851970 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.48494633 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.45474405 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45318840 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.39814485 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39199679 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.38716363 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.37014690 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36722034 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33666604 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.31666827 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.26790058 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26328940 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25518337 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25165111 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24860707 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.23224724 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18632679 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16799863 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13695101 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13600513 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11134183 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10042902 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09463004 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08962578 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08464661 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07261223 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04176853 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02625573 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02357943 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 1.02276631 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01740750 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01496625 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 1.01400572 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00070302 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99322903 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97629029 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.96023663 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.94913543 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93405141 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91375795 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89751489 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87338076 |
| 72 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86378040 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86144883 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85801344 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84433326 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84100176 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83325085 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82764812 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.81999690 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81820402 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81559942 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80615062 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80346841 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80333310 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80197589 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80111242 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78209877 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.77196137 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.75981113 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75887029 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74746956 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74721524 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74382997 |
| 94 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.74137644 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74120697 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74106582 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73549254 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73526826 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72048225 |
| 100 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71741702 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.71640306 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71382619 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71013247 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70435257 |
| 105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70236301 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69544116 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69448293 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67932318 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67362456 |
| 110 | Measles_Homo sapiens_hsa05162 | 0.67225947 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66179497 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66040118 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65732784 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64257305 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62846245 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62801634 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62612645 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62553262 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62262851 |
| 120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62193557 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.61307299 |
| 122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61287920 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61020366 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.60049306 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59406194 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58626439 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.58547906 |
| 128 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58048410 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56565723 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56332914 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56209794 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55286518 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55179365 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.54805495 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54015118 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53272730 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53259015 |
| 138 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53239153 |
| 139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52470546 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52202321 |
| 141 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51285904 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50307804 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50288730 |
| 144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49879652 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49828834 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47784817 |
| 147 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46571754 |
| 148 | Malaria_Homo sapiens_hsa05144 | 0.45031485 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44365003 |
| 150 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42970653 |
| 151 | Focal adhesion_Homo sapiens_hsa04510 | 0.42437594 |
| 152 | Legionellosis_Homo sapiens_hsa05134 | 0.42382208 |
| 153 | Bladder cancer_Homo sapiens_hsa05219 | 0.41524279 |
| 154 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40512041 |
| 155 | Melanoma_Homo sapiens_hsa05218 | 0.40373469 |
| 156 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40137634 |
| 157 | Asthma_Homo sapiens_hsa05310 | 0.39470248 |
| 158 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37477259 |
| 159 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36552364 |

